miR-639 promotes the proliferation and invasion of breast cancer cell in vitro

Cancer Cell International

Fang Wang¹  Peng-wei Lv¹  Xin-guang Qiu¹  Lin Li¹ 

[1]Department of Breast Surgey, the First Affiliated Hospital of Zhengzhou University, No. 1, East Jian she Road, Zhengzhou 450052 Henan Province, China

关键词: Metastases;    Invasion;    Breast cancer;    miR-639;   

Others  :  792046
DOI  :  10.1186/1475-2867-14-39

 received in 2014-02-22, accepted in 2014-05-01,  发布年份 2014

【 摘 要 】

Breast cancer is characterised by an elevated capacity for tumour invasion and lymph node metastasis, but the cause remains to be determined. Recent studies suggest that microRNAs can regulate the evolution of malignant behaviours by regulating multiple target genes. In this study, we have first confirmed that miR-639 is up-regulated in metastatic breast cancer tissues and cell line with highly invasive capacity. Furthermore, we provided evidence to demonstrate that up-regulation of miR-639 contributes breast cancer invasion and metastasis. These data reveal a key role of miR-639 in breast cancer metastasis and support biological and clinical links between miR-639 and breast cancer.

【 授权许可】

   
2014 Li et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Zhang XH, Giuliano M, Trivedi MV, Schiff R, Osborne CK: Metastasis dormancy in estrogen receptor-positive breast cancer. Clin Cancer Res 2013, 19(23):6389-6397.
• [2]Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 2009, 136(2):215-233.
• [3]Schickel R, Boyerinas B, Park SM, Peter ME: MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008, 27(45):5959-5974.
• [4]Zhang J, Guo H, Qian G, Ge S, Ji H, Hu X, Chen W: MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network. Mol Cancer 2010, 9:211.
• [5]Ventura A, Jacks T: MicroRNAs and cancer: short RNAs go a long way. Cell 2009, 136(4):586-591.
• [6]Kent OA, Mendell JT: A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006, 25(46):6188-6196.
• [7]Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6(11):857-866.
• [8]Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, Tian W, Zhang Q, Wang C, Zhang Q, Zhuang SM, Zheng L, Liang A, Tao W, Cao X: Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011, 19(2):232-243.
• [9]Ragusa M, Caltabiano R, Russo A, Puzzo L, Avitabile T, Longo A, Toro MD, Di Pietro C, Purrello M, Reibaldi M: MicroRNAs in vitreus humor from patients with ocular diseases. Mol Vis 2013, 19:430-440.
• [10]Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Muller SC, Ellinger J: Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? World J Urol 2012, 32(2):353-358.
• [11]Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T: Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007, 39(5):673-677.
• [12]Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR: MicroRNA expression profiles classify human cancers. Nature 2005, 435(7043):834-838.
• [13]Ozen M, Creighton CJ, Ozdemir M, Ittmann M: Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 2008, 27(12):1788-1793.
• [14]Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006, 103(7):2257-2261.
• [15]Sun Q, Zhang J, Cao W, Wang X, Xu Q, Yan M, Wu X, Chen W: Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin. Int J Biochem Cell Biol 2013, 45(3):513-520.
• [16]O’Regan EM, Toner ME, Finn SP, Fan CY, Ring M, Hagmar B, Timon C, Smyth P, Cahill S, Flavin R, Sheils OM, O'Leary JJ: p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Hum Pathol 2008, 39(3):452-458.
• [17]Klinge CM: Estrogen regulation of MicroRNA expression. Curr Genomics 2009, 10(3):169-183.
• [18]Wu S, Huang S, Ding J, Zhao Y, Liang L, Liu T, Zhan R, He X: Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region. Oncogene 2010, 29(15):2302-2308.